Literature DB >> 25921910

Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival.

Marilyn L Kwan1, Philip S Bernard2, Candyce H Kroenke2, Rachel E Factor2, Laurel A Habel2, Erin K Weltzien2, Adrienne Castillo2, Erica P Gunderson2, Kaylynn S Maxfield2, Inge J Stijleman2, Bryan M Langholz2, Charles P Quesenberry2, Lawrence H Kushi2, Carol Sweeney2, Bette J Caan2.   

Abstract

BACKGROUND: Breastfeeding is associated with decreased breast cancer risk, yet associations with prognosis and survival by tumor subtype are largely unknown.
METHODS: We conducted a cohort study of 1636 women from two prospective breast cancer cohorts. Intrinsic tumor subtype (luminal A, luminal B, human epidermal growth factor receptor 2 [HER2]-enriched, basal-like) was determined by the PAM50 gene expression assay. Breastfeeding history was obtained from participant questionnaires. Questionnaires and medical record reviews documented 383 recurrences and 290 breast cancer deaths during a median follow-up of nine years. Multinomial logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) between breastfeeding and tumor subtype. Cox regression was used to estimate hazard ratios (HRs) for breast cancer recurrence or death. Statistical significance tests were two-sided.
RESULTS: Breast cancer patients with basal-like tumors were less likely to have previously breastfed than those with luminal A tumors (OR = 0.56, 95% CI = 0.39 to 0.80). Among all patients, ever breastfeeding was associated with decreased risk of recurrence (HR = 0.70, 95% CI = 0.53 to 0.93), especially breastfeeding for six months or more (HR = 0.63, 95% CI = 0.46 to 0.87, P trend = .01). Similar associations were observed for breast cancer death. Among women with luminal A subtype, ever breastfeeding was associated with decreased risks of recurrence (HR = 0.52, 95% CI = 0.31 to 0.89) and breast cancer death (HR = 0.52, 95% CI = 0.29 to 0.93), yet no statistically significant associations were observed among the other subtypes. Effects appeared to be limited to tumors with lower expression of proliferation genes.
CONCLUSIONS: History of breastfeeding might affect prognosis and survival by establishing a luminal tumor environment with lower proliferative activity.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2015        PMID: 25921910      PMCID: PMC4554253          DOI: 10.1093/jnci/djv087

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  38 in total

1.  Differentiation and breast cancer.

Authors:  J Russo; I H Russo
Journal:  Medicina (B Aires)       Date:  1997       Impact factor: 0.653

2.  Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.

Authors:  Amanda I Phipps; Rowan T Chlebowski; Ross Prentice; Anne McTiernan; Jean Wactawski-Wende; Lewis H Kuller; Lucile L Adams-Campbell; Dorothy Lane; Marcia L Stefanick; Mara Vitolins; Geoffrey C Kabat; Thomas E Rohan; Christopher I Li
Journal:  J Natl Cancer Inst       Date:  2011-02-23       Impact factor: 13.506

3.  The impact of confounder selection criteria on effect estimation.

Authors:  R M Mickey; S Greenland
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

4.  Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger.

Authors:  Mia M Gaudet; Michael F Press; Robert W Haile; Charles F Lynch; Sally L Glaser; Joellen Schildkraut; Marilie D Gammon; W Douglas Thompson; Jonine L Bernstein
Journal:  Breast Cancer Res Treat       Date:  2011-06-11       Impact factor: 4.872

5.  The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California.

Authors:  Marilyn L Kwan; Christine B Ambrosone; Marion M Lee; Janice Barlow; Sarah E Krathwohl; Isaac Joshua Ergas; Christine H Ashley; Julie R Bittner; Jeanne Darbinian; Keren Stronach; Bette J Caan; Warren Davis; Susan E Kutner; Charles P Quesenberry; Carol P Somkin; Barbara Sternfeld; John K Wiencke; Shichun Zheng; Lawrence H Kushi
Journal:  Cancer Causes Control       Date:  2008-05-14       Impact factor: 2.506

6.  Supervised risk predictor of breast cancer based on intrinsic subtypes.

Authors:  Joel S Parker; Michael Mullins; Maggie C U Cheang; Samuel Leung; David Voduc; Tammi Vickery; Sherri Davies; Christiane Fauron; Xiaping He; Zhiyuan Hu; John F Quackenbush; Inge J Stijleman; Juan Palazzo; J S Marron; Andrew B Nobel; Elaine Mardis; Torsten O Nielsen; Matthew J Ellis; Charles M Perou; Philip S Bernard
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

7.  Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer.

Authors:  Amanda I Phipps; Kathleen E Malone; Peggy L Porter; Janet R Daling; Christopher I Li
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

8.  Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept.

Authors:  Werner Böcker; Roland Moll; Christopher Poremba; Roland Holland; Paul J Van Diest; Peter Dervan; Horst Bürger; Daniel Wai; Raihanatou Ina Diallo; Burkhard Brandt; Hermann Herbst; Ansgar Schmidt; Markus M Lerch; Igor B Buchwallow
Journal:  Lab Invest       Date:  2002-06       Impact factor: 5.662

9.  Characterization of uncertainty in the classification of multivariate assays: application to PAM50 centroid-based genomic predictors for breast cancer treatment plans.

Authors:  Mark Tw Ebbert; Roy Rl Bastien; Kenneth M Boucher; Miguel Martín; Eva Carrasco; Rosalía Caballero; Inge J Stijleman; Philip S Bernard; Julio C Facelli
Journal:  J Clin Bioinforma       Date:  2011-12-23

10.  PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.

Authors:  Roy R L Bastien; Álvaro Rodríguez-Lescure; Mark T W Ebbert; Aleix Prat; Blanca Munárriz; Leslie Rowe; Patricia Miller; Manuel Ruiz-Borrego; Daniel Anderson; Bradley Lyons; Isabel Álvarez; Tracy Dowell; David Wall; Miguel Ángel Seguí; Lee Barley; Kenneth M Boucher; Emilio Alba; Lisa Pappas; Carole A Davis; Ignacio Aranda; Christiane Fauron; Inge J Stijleman; José Palacios; Antonio Antón; Eva Carrasco; Rosalía Caballero; Matthew J Ellis; Torsten O Nielsen; Charles M Perou; Mark Astill; Philip S Bernard; Miguel Martín
Journal:  BMC Med Genomics       Date:  2012-10-04       Impact factor: 3.063

View more
  13 in total

1.  17β-Estradiol alters oxidative damage and oxidative stress response protein expression in the mouse mammary gland.

Authors:  Lisi Yuan; Alicia K Dietrich; Yvonne S Ziegler; Ann M Nardulli
Journal:  Mol Cell Endocrinol       Date:  2016-02-09       Impact factor: 4.102

2.  Pre-diagnostic breastfeeding, adiposity, and mortality among parous Hispanic and non-Hispanic white women with invasive breast cancer: the Breast Cancer Health Disparities Study.

Authors:  Avonne E Connor; Kala Visvanathan; Kathy B Baumgartner; Richard N Baumgartner; Stephanie D Boone; Lisa M Hines; Roger K Wolff; Esther M John; Martha L Slattery
Journal:  Breast Cancer Res Treat       Date:  2016-11-11       Impact factor: 4.872

3.  TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study.

Authors:  Amber N Hurson; Mustapha Abubakar; Alina M Hamilton; Kathleen Conway; Katherine A Hoadley; Michael I Love; Andrew F Olshan; Charles M Perou; Montserrat Garcia-Closas; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-11-04       Impact factor: 4.090

4.  Perinatal Depression Among HIV-Infected Women in KwaZulu-Natal South Africa: Prenatal Depression Predicts Lower Rates of Exclusive Breastfeeding.

Authors:  Emily L Tuthill; Jennifer A Pellowski; Sera L Young; Lisa M Butler
Journal:  AIDS Behav       Date:  2017-06

5.  Counseling About the Maternal Health Benefits of Breastfeeding and Mothers' Intentions to Breastfeed.

Authors:  Megan Ross-Cowdery; Carrie A Lewis; Melissa Papic; Jennifer Corbelli; Eleanor Bimla Schwarz
Journal:  Matern Child Health J       Date:  2017-02

Review 6.  Can Nutrition Lower the Risk of Recurrence in Breast Cancer?

Authors:  Julia Weigl; Hans Hauner; Dagmar Hauner
Journal:  Breast Care (Basel)       Date:  2018-04-20       Impact factor: 2.860

7.  Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

Authors:  Anna Morra; Audrey Y Jung; Marjanka K Schmidt; Jenny Chang-Claude; Sabine Behrens; Renske Keeman; Thomas U Ahearn; Hoda Anton-Culver; Volker Arndt; Annelie Augustinsson; Päivi K Auvinen; Laura E Beane Freeman; Heiko Becher; Matthias W Beckmann; Carl Blomqvist; Stig E Bojesen; Manjeet K Bolla; Hermann Brenner; Ignacio Briceno; Sara Y Brucker; Nicola J Camp; Daniele Campa; Federico Canzian; Jose E Castelao; Stephen J Chanock; Ji-Yeob Choi; Christine L Clarke; Fergus J Couch; Angela Cox; Simon S Cross; Kamila Czene; Thilo Dörk; Alison M Dunning; Miriam Dwek; Douglas F Easton; Diana M Eccles; Kathleen M Egan; D Gareth Evans; Peter A Fasching; Henrik Flyger; Manuela Gago-Dominguez; Susan M Gapstur; José A García-Sáenz; Mia M Gaudet; Graham G Giles; Mervi Grip; Pascal Guénel; Christopher A Haiman; Niclas Håkansson; Per Hall; Ute Hamann; Sileny N Han; Steven N Hart; Mikael Hartman; Jane S Heyworth; Reiner Hoppe; John L Hopper; David J Hunter; Hidemi Ito; Agnes Jager; Milena Jakimovska; Anna Jakubowska; Wolfgang Janni; Rudolf Kaaks; Daehee Kang; Pooja Middha Kapoor; Cari M Kitahara; Stella Koutros; Peter Kraft; Vessela N Kristensen; James V Lacey; Diether Lambrechts; Loic Le Marchand; Jingmei Li; Annika Lindblom; Jan Lubiński; Michael Lush; Arto Mannermaa; Mehdi Manoochehri; Sara Margolin; Shivaani Mariapun; Keitaro Matsuo; Dimitrios Mavroudis; Roger L Milne; Taru A Muranen; William G Newman; Dong-Young Noh; Børge G Nordestgaard; Nadia Obi; Andrew F Olshan; Håkan Olsson; Tjoung-Won Park-Simon; Christos Petridis; Paul D P Pharoah; Dijana Plaseska-Karanfilska; Nadege Presneau; Muhammad U Rashid; Gad Rennert; Hedy S Rennert; Valerie Rhenius; Atocha Romero; Emmanouil Saloustros; Elinor J Sawyer; Andreas Schneeweiss; Lukas Schwentner; Christopher Scott; Mitul Shah; Chen-Yang Shen; Xiao-Ou Shu; Melissa C Southey; Daniel O Stram; Rulla M Tamimi; William Tapper; Rob A E M Tollenaar; Ian Tomlinson; Diana Torres; Melissa A Troester; Thérèse Truong; Celine M Vachon; Qin Wang; Sophia S Wang; Justin A Williams; Robert Winqvist; Alicja Wolk; Anna H Wu; Keun-Young Yoo; Jyh-Cherng Yu; Wei Zheng; Argyrios Ziogas; Xiaohong R Yang; A Heather Eliassen; Michelle D Holmes; Montserrat García-Closas; Soo Hwang Teo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-01-26       Impact factor: 4.090

8.  Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.

Authors:  Merete Ellingjord-Dale; Linda Vos; Steinar Tretli; Solveig Hofvind; Isabel Dos-Santos-Silva; Giske Ursin
Journal:  Breast Cancer Res       Date:  2017-01-23       Impact factor: 6.466

9.  Epidemiology of Basal-like and Luminal Breast Cancers among Black Women in the AMBER Consortium.

Authors:  Halei C Benefield; Gary R Zirpoli; Emma H Allott; Yue Shan; Amber N Hurson; Angela R Omilian; Thaer Khoury; Chi-Chen Hong; Andrew F Olshan; Traci N Bethea; Elisa V Bandera; Julie R Palmer; Christine B Ambrosone; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-23       Impact factor: 4.254

10.  Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population.

Authors:  Mustapha Abubakar; Hyuna Sung; Devi Bcr; Jennifer Guida; Tieng Swee Tang; Ruth M Pfeiffer; Xiaohong R Yang
Journal:  Breast Cancer Res       Date:  2018-09-18       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.